All 22,000 - DNA & RNA
Helping predict response and
classify cancer types
We help you and your oncologist identify therapies with potentially greater benefit, while ruling out those that are less likely to work.
We match each patient’s unique biomarker profile to potential clinical trials.
No two tumors are alike. Therefore, it is imperative to have as much information about your cancer as possible in order to make personalized treatment choices. Molecular profiling can identify biomarkers in your tumor that provide important insights on whether your tumor may or may not respond to specific drugs or clinical trials.
Biomarkers are many different compounds in the body that indicate something about your health. Cancer biomarkers are typically proteins, genes and other molecules that affect how cancer cells grow, multiply, die and respond to treatment. Some cancer biomarkers can be used to predict how aggressively your cancer will grow and are useful for determining your prognosis. These biomarkers can also be used to identify the therapies most likely to target the cancer cells in your tumor.
When a sample from your tumor undergoes molecular profiling, your oncologist receives a report that lists the molecular biomarkers that make up your tumor. This unique information can help your oncologist personalize your treatment plan by predicting which treatments your cancer is likely to respond to.
If you are a patient or caregiver and have questions about Caris molecular profiling please contact us today.